[JNJ] JNJ Dividend Analysis: Is Johnson & Johnson a Buy Now?
[MARKET INSIGHTS] In the current volatile equities environment, income-seeking investors often pivot toward defensive stalwarts. This JNJ Dividend Analysis examines whether Johnson & Johnson remains the premier “Dividend King” for a diversified portfolio. Following the strategic spin-off of its consumer health division, Kenvue, the company has transitioned into a high-margin pharmaceutical and MedTech powerhouse, offering … Read more